Abstract
Taking into account the ability of vitamin B6 vitamers (i.e., pyridoxal, pyridoxine, pyridoxamine) to stimulate adrenomedullary catecholamine outflow and biochemical and cardiovascular changes consistent with adrenoceptor stimulation, this study was undertaken in mice to verify the possibility that pyridoxal (PL), the most potent of the B6 vitamers, could enter into an adverse vitamin-drug interaction when coadministered with a cardioactive drug, and that compounds like taurine (TAU) and labetalol (LAB) could be protective. To this end, mice were treated with PL (200 mg/kg) and isoproterenol (ISO 200 mg/kg), with and without a pretreatment with TAU (300 mg/kg), LAB (30 mg/kg), or TAU plus LAB, and monitored for heart rate, electrocardiographic (ECG) and myocardial electrolyte changes. PL plus ISO lowered the LD50 of ISO and magnified the changes in heart rate, ECG and myocardial electrolytes seen with ISO alone. Pretreating rats with TAU or TAU plus LAB attenuated the cardiovascular changes induced by PL plus ISO to a greater extent than LAB alone. The attenuating actions of TAU and LAB probably reflect independent and complementary mechanisms of action.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Arnold LE (2001) Alternative treatments for adults with attention-deficit hyperactivity disorder (ADHD). Ann NY Acad Sci 931:310–341
Barletta MA, Lehr D, Guideri G (1978) Hemodynamic alterations in isoproterenol-induced myocardial cardiac arrhythmias in corticoid-treated rats. J Pharm Sci 67:1390–1394
Braunwald E (1971) Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 27:416–432
Drew GM, Hilditch A, Levy GP (1979) The relationship between the cardiovascular effects, alpha- and beta-adrenoreceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats. Clin Exp Hypertens 1:597–611
Furushima H, Chinushi M, Washizuka T, Aizawa Y (2001) Role of α-blockade in congenital long QT syndrome investigation by exercise. Jpn Circ J 65:654–658
Grubb BP (1991) The use of oral labetalol in the treatment of arrhythmias associated with the long QT syndrome. Chest 100:1724–1725
Guideri G, Barletta M, Lehr D (1974) Extraordinary potentiation of isoproterenol cardiotoxicity by corticoid pretreatment. Cardiovasc Res 8:775–786
Guideri G, Barletta M, Chau R, Green M, Lehr D (1975) Method for the production of severe ventricular dysrhythmias in small laboratory animals. Recent Adv Stud Cardiac Struct Metab 10:661–679
Hoffman B, Lefkowitz R (1995) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, McGraw-Hill, New York, pp 212–214
Kleijnen J, Knipschild P (1991) Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans. Biol Psychiatry 29:931–941
Lau-Cam CA, Thadikonda KP, Kendall, BF (1991) Stimulation of rat liver glycogenolysis by vitamin B6: a role for adrenal catecholamines. Res Commun Chem Pathol Pharmacol 73:197–207
Manger WM (1982) Catecholamines in normal and abnormal cardiac function. In: Kellerman JJ, Hashomer T (eds) Advances in cardiology, Karger Publishers, New York, pp 24–27
Mitchell GF, Jeron A, Koren G (1998) Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol 274 (Pt 2):H747–H751
Nakagawa K, Kuriyama K (1975) Effect of taurine on alteration in adrenal functions induced by stress. Jpn J Pharmacol 25:737–746
Patel JP, Lau-Cam CA (2006) Taurine attenuates pyridoxal-induced adrenomedullary catecholamine release and glycogenolysis in the rat. In: Oja SS, Saransaari P (eds) Taurine 6, Springer, New York, pp 147–156
Read WO, Welty JD (1963) Effect of taurine on epinephrine and digoxin induced irregularities of the dog heart. J Pharmacol Exp Ther 139:283–289
Saber S (1987) Elucidation of the mechanism of cardiotoxicity of vitamin B6 in rats, PhD Thesis, St John’s University, Jamaica, New York
Satoh H, Sperelakis N (1998) Review of some actions of taurine on ion channels of cardiac muscle cells and others. Gen Pharmacol 30:451–463
Urao N, Shiraishi H, Ishibashi K, Hyogo M, Tsukamoto M, Keira N, Hirasaki S, Shirayama T, Nakagawa M (2004) Idiopathic long QT syndrome with early afterdepolarization induced by epinephrine. A case report. Circ J 68:587–591
Welty MC, Welty JD, McBroom MJ (1982) Effect of isoproterenol and taurine on heart calcium in normal and cardiomyopathic hamsters. J Mol Cell Cardiol 14:353–357
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this paper
Cite this paper
Acharya, M., Lau-Cam, C.A. (2009). Attenuating Action of Taurine and Labetalol on Cardiovascular Alterations by Pyridoxal-Isoproterenol, a Vitamin-Drug Interaction with Cardiopathologic Significance. In: Azuma, J., Schaffer, S.W., Ito, T. (eds) Taurine 7. Advances in Experimental Medicine and Biology, vol 643. Springer, New York, NY. https://doi.org/10.1007/978-0-387-75681-3_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-75681-3_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-75680-6
Online ISBN: 978-0-387-75681-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)